Targeting USP1‐dependent KDM4A protein stability as a potential prostate cancer therapy

The histone demethylase lysine‐specific demethylase 4A (KDM4A) is reported to be overexpressed and plays a vital in multiple cancers through controlling gene expression by epigenetic regulation of H3K9 or H3K36 methylation marks. However, the biological role and mechanism of KDM4A in prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Shu‐Zhong, Lei, Zi‐Ying, Guan, Tian‐Pei, Fan, Ling‐Ling, Li, You‐Qiang, Geng, Xin‐Yan, Fu, De‐Xue, Jiang, Hao‐Wu, Xu, Song‐Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226285/
https://www.ncbi.nlm.nih.gov/pubmed/32133742
http://dx.doi.org/10.1111/cas.14375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226285/
https://www.ncbi.nlm.nih.gov/pubmed/32133742
http://dx.doi.org/10.1111/cas.14375

Ejemplares similares